distributor expect focu possibl opioid litig settlement
see potenti beat gener inflat expect guid bracket
consensu see upsid guidanc due unusu quarterli
progress impli guid expect guidanc
expect investor focus possibl opioid litig settlement recent
wall street journal wsj report distributor talk collect pay
year settl opioid litig possibl settlement also report
new york time reuter believ fact multipl news sourc
report possibl settlement indic discuss progress
expect may forthcom said first trial multidistrict
litig set start next monday octob go quarter see
potenti distributor report result ahead consensu due gener inflat
typic posit driver distributor gener price analysi indic
gener inflat qtd august compar gener
bp improv gener price y/i notabl expect bracket consensu
see upsid consensu given comment last week
fundament improv see upsid guidanc also given management rais
adj ep guidanc top-end bottom-end despit
beat last quarter moreov guidanc guidanc impli unusu back-
half quarterli progress adj ep q/q even though typic
strongest quarter year adj ep basi believ strong result
increas view current outlook prove pretti conserv
despit recent move like setup go quarter ep estim
expect management provid adj ep guidanc bracket consensu
estim estim y/i adj op incom growth retail
usa retail pharma pharma wholesal total adj op incom
growth y/i adj ep growth driven share repo assumpt
addit think investor continu focu long-term futur vision
particularli store format go forward progress partnership
dplo intend provid updat regard progress strateg
review requir feel appropri look updat regard
strateg review specialti expect updat regard management strategi
partner health system payor drive greater volum pbm look
comment regard custom retent sell season
page summari estim chang
pleas see page report import disclosur
thomson eikon cowen compani
iqvia cowen compani
note data quarter-to-d august
iqvia cowen compani
million expect per share data
thomson eikon cowen compani
changedistribut oper oper bpsnanaoth oper oper bpsnanatot gross gross bpsadj oper oper bpsadj guidanc bracket consensu expect guidanc bracket consensu analysi indic rang rel consensu base assumpt y/i pharmaceut distribut adj oper incom growth y/i servic adj oper incom growth expect guid y/i adj oper incom growth pharmaceut distribut base normal adj oper incom grow estim y/i exclud certain non-recurring headwind tailwind note see potenti upsid estim management includ increment contribut pharmedium expect guid y/i adj oper incom growth servic base assumpt issu relat fusion implement lash rectifi lash return growth profit recal without headwind due fusion implement servic adj oper incom growth wouldv double-digit assum repurchas common share see potenti upsid estim adj ep in-line consensu see potenti upsid pharmaceut distribut segment consider improv gener price rel compar quarter last year similar last two quarter recal pharmaceut distribut result came better expect believ primarili due moder gener inflat gener price analysi indic gener inflat qtd august compar gener deflat bp improv gener price y/i cowen estimatesconsensu estim cowen
million expect per share data
thomson eikon cowen compani
chang oper oper bpsnanamed oper oper bpsnanatot bpsadj oper oper bpsadj potenti upsid pharma segment estim adj ep in-line consensu see potenti upsid segment consider y/i moder gener deflat gener price analysi indic gener inflat qtd august compar gener deflat bp improv gener price y/i stabil medic perform medic underwhelm due issu brand product management expect normal perform surfac medic oper profit guidanc look ambiti think achiev result dampen non-recurring charg relat exclus distribut agreement cordi supplier well impact tsa exit statu cfo search departur jorg gomez cfo effect august expect management provid updat regard cfo search last quarter management note engag extern search next cfo perman cfo appoint dave evan serv interim cfo updat cost optim look updat cost optim program realiz save expect deliv increment save last quarter management express confid achiev save rel baselin five year less updat estim maintain price target slightli rais adj ep estim respect howev maintain price target base revis dcf analysi impli share trade adj ep estim estimatesconsensu estimatesmarket performr cowen
million expect per share data
thomson eikon cowen compani
changeu pharma specialti pharma specialti oper pharma specialti oper bpsnanaeuropean pharma pharma oper pharma oper bpsnanamedical-surg oper oper bpsnanaoth oper oper bpsnanatot bpsadj oper bpsadj potenti upsid estim adj ep in-line consensu see potenti upsid pharma specialti segment consider y/i moder gener deflat gener price analysi indic gener inflat qtd august compar gener deflat bp improv gener price y/i updat retail pharmaci busi expect anoth updat regard execut restructur action includ store ration cost action well updat regard reimburs environ last quarter management note nh new commun pharmaci contractu framework brought greater clairti long-term certainti maintain current level industri fund next year although certain element fund alloact fulli defin recal due weak retail pharmaci environ management revis outlook low-end origin assumpt low- mid-singl digit growth statu ipo look updat regard progress time exit invest last quarter management note number mileston must met prior exit includ lock-up period follow ipo blackston opportun secondari offer period follow lock-up period given mileston exit could extend period month depend necess certain mileston may opportun exit end estim price target rais adj ep estim slightli lower adj ep estim howev maintain price target base revis dcf analysi impli share trade adj ep estim estimatesconsensu estim cowen
million expect per share data
thomson eikon cowen compani
changepbm adj oper adj oper bpsnanatot adjust adj oper adj oper bpsnanapharmaci bpsnanafront-end bpsnanatot bpsnanahcb nananahcb adj oper nananahcb adj oper benefit gross gross bpsadj oper oper bpsadj pbm sell season rebat guarante expect management provid updat sell season last qtr stand net win report improv net loss provid analyst day renew left unfinish outperform comment call adjust price underwrit pbm contract reflect lower drug inflat trend believ indic headwind rebat guarante may eas convers consult suggest success renegoti rebat guarante true think would present upsid mgmt pbm guidanc updat medic cost trend base recent employ trend survey see materi chang gross medic cost trend expect corrobor comment survey indic expect current yr medic cost trend appear rel consist last yr plural respond expect y/i increas similar last yr expect also fairli consist current yr prior yr suggest us employ see expect materi chang gross medic cost trend expect similar comment progress healthhub expect management provid us updat healthhub strategi perform open healthhub houston tx area recent trip one healthhub left us posit view strategi look comment potenti uplift f-e sale margin given shift toward higher margin product like dme addit look detail regard plan expans add metropolitan area atlanta philadelphia tampa later yr updat synergi enterpris modern expect management provid updat synergi enterpris modern program could indic whether mgmt medium- long-term guidanc rang achiev last qtr management rais synergi target higher end although remain unchang earli stage execut enterpris modern effort expect gener save beyond see upsid guidanc believ guidanc may prove conserv particularli management rais adj ep guidanc midpoint despit beat last qtr addit guidanc guidanc impli unusu back-half quarterli progress adj ep q/q even though typic strongest qtr yr cowen estimatesconsensu estim cowen
million expect per share data
thomson eikon cowen compani
changeretail usa usa fifo gross usa fifo gross bpsnanaretail usa adj oper usa adj oper bpsnanaretail pharma pharma adj gross pharma adj gross bpsnanaretail pharma adj oper pharma adj oper bpsnanapharma wholesal wholesal adj gross wholesal adj gross bpsnanapharma wholesal adj oper wholesal adj oper bpsnananet gross gross bpsadj oper oper bpsadj performcowen estimatesconsensu estimatesexpect result in-line consensu estim report adj ep in-line consensu estim net revenu slightli consensu adj oper incom higher consensu retail usa estim pharmaci compstore y/i same-stor prescript y/i estim retail compstore y/i partli due continu de-emphasi tobacco weigh retail compstore detail regard long-term vision think investor continu focu long-term futur vision particularli fit value-bas care environ far management convey investor intend pursu store-in-stor partnership strategi look anyth increment regard compani numer pilot partner specif regard recent announc strateg partnership rxadvanc introduc innov model pharmaci management base know far approach appear one provid infrastructur other coordin care time benefit greater traffic announc partnership remain mostli pilot phase anecdot evid suggest approach may find success progress mitig effort order mitig headwind management acceler digit transform restructur retail offer creat neighborhood health destin around modern pharmaci roll transform manag program expect updat regard initi help determin achiev management long-term guidanc mid- high-singl digit adj ep growth management expect realiz benefit annual save excess transform manag program reduc annual cash spend guidanc bracket consensu expect management provid adj ep guidanc bracket consensu estim estim y/i adj oper incom growth retail usa retail pharma pharma wholesal total adj oper incom growth y/i adj ep growth driven share repurchas assumpt cowen
million expect per share data
thomson eikon cowen compani
changenet bpsadjust ebitda performupd strateg review dplo intend provid updat regard progress strateg review requir feel appropri look updat regard strateg review includ limit sale merger compani continu stand-alon compani capit structur chang sale disposit certain busi asset progress specialti partnership strategi expect anoth updat regard management strategi partner health system payor drive greater volum specialti last quarter management note dplo gain traction see opportun across pipelin addit management announc number new win includ bcb kansa bcb vermont healthpartn minnesota wellcar kentucki notabl look insight volum could look like custom retent sell season castiarx earlier year management lower pbm revenu guidanc incur custom loss due neg percept low servic level management focus improv servic level retain custom go forward last quarter management also point robust pipelin focu dplo abil convert pipelin new win given last year strong rfp activ translat signific new win similar specialti segment look insight whether management turnaround effort posit castiarx posit growth effici realiz asid perform underli busi would focu dplo track toward achiev oper effici recal last quarter management note cost save oper effici run behind schedul attribut downward adj ebitda guidanc revis dplo expect cost save annual run-rat origin assum previou guidanc rang updat estim maintain price target slightli lower adj ebitda estim respect also maintain price target base revis dcf analysi impli share trade adj ebitda estim cowen estimatesconsensu estim cowen
thomson eikon cowen compani
million except per-shar data
cowen compani
model assumptionstermin growth depreci chang work capit valuefre free futur excess number per end septemb cowen
million except per-shar data
compani report cowen compani
cost good gross margin ebitda ebit losses/ incom affili exp tax incom conv sub note deal-rel sever litig incom cont incom deal-rel incom ex-discontinu average ep ex discontinu chang incom cont ep cont end septemb cowen
million except per-shar data
compani report cowen compani
cost good gross margin ebitda ebit losses/ incom affili exp tax incom conv sub note deal-rel sever litig own net incom deal-rel incom ex-discontinu average ep ex-discontinu chang year-over-year total incom cont ep cont cowen
million
compani report cowen compani
asset receiv net doubt expens current charg total liabil account payabl incom current equiti common paid-in earn comprehens commmon stock total stockhold liabil stockhold liquid ratio current sale purchas acct ratio inventori structur long-term solvenc ratio total debt total interest ratio return commit capit asset averag stockhold equiti cowen
million
compani report cowen compani
income/ loss flow oper activ depreci provis loss account sale invest employe stock defer incom invest impair oper asset liabil account merchandis prepaid expens account payabl accru expens incom net cash oper acquisit properti acquisit purchas treasuri dividend common proceeds/ repay debt net increase/ decreas cash equival begin cash equival end summari oper year end septemb cowen
million
compani report cowen compani
activitiesnet loss incom discontinu incom continu adjust reconcil net incom provis loss account provis defer incom employe stock loss dispos properti equipment- impair charg equiti investment- lifo pension settlement- includ intang asset loss earli retir chang oper asset liabil account merchandis prepaid expens account payabl accru expens incom net cash provid use oper activ continu net cash provid use oper activ discontinu net cash provid use oper invest activitiescapit acquir compani net cash proce sale properti equipment- equiti proce sale business- purchas invest secur avail sale- net cash provid use invest activ continu net cash provid use invest activ discontinu ops- net cash provid use invest financ activitiesborrow revolv securit credit purchas treasuri payment premium earli retir debt- defer financ cost other- exercis warrants- exercis stock dividend common purchas cap call net cash provid use financ activ continu net cash provid use financ activ discontinu op net cash provid use financ increas cash cash cash equival begin cash equival end fiscal year end septemb cowen
million except per share data
cowen compani
model assumptionstermin growth tax depreci chang work terminal- capit valuefre pv npv free npv futur excess valu total number valu per fiscal year end june cowen
million except per share data
cowen compani
good gross gross chang sell gener oper interest pre-tax incom tax incom continu net incom deal-rel discontinu operations- non-recurring net incom dilut weight averag ep continu ep deal-rel ep non-recurring ex-disc ep chang year-over-year oper incom continu continu year end june cowen
million except per share data
cowen compani
good gross gross chang sell gener oper interest pre-tax pre-tax incom tax net earn attribut non-controlling net incom continu net incom deal-rel discontinu operations- non-recurring net incom dilut weight averag adj chang year-over-year oper incom continu continu cowen
million
cowen compani
asset trade receiv merchandis prepaid expens asset held sale discontinu ops- current pp goodwil total current liabil current portion long-term account accru liabil busi held sale disc ops- current long-term defer tax redeem non-controlling stockhold equiti common retain common share cumul foreign currenc non-controlling total stockhold total liabil stockhold short-term liquid ratio current sale day purchas account inventori ratio inventori capit structur long-term solvenc ratio total debt total interest ratio return invest capit averag total asset averag stockhold equiti year end june cowen
million
cowen compani
income/ loss cumul effect chang accounting- earn /loss discontinu operations- earn cont op b/f effect chg flow oper activ depreci sale provis loss account charg reorg busi charges- sale invest businesses- employe stock defer incom invest impair chang oper asset liabil account merchandis prepaid expens assets- account oper net cash use /provid op activ disc ops- net cash oper acquisit properti acquisit issuanc common purchas treasuri dividend common proceeds/ purchas secur proceeds/ repay debt net increase/ decreas cash equival begin cash equival end cowen summari capit owner financ non-recur year end june cowen
million
compani report cowen compani
flow oper activitiesnet cumul effect chang accounting- earn /loss discontinu earn cont op cumul effect chang adjust reconcil net earn net cash depreci sale asset loss debt sale carefus common stock- purchas in-process d- equiti provis defer incom tax provis bad debt chang fair valu conting consider oblig chang oper asset liabil net increas trade receiv increas increas net invest sales-typ leases- increas account oper item net net cash use /provid oper activ discontinu ops- net cash provid oper flow invest activ acquisition/divestitur subsidiari net cash acquir proce sale properti equip addit properti equip sale/ purchas market secur avail sale proce matur available-for-sal proce divestitur dispos held sale proce sale carefus common stock- net cash use /provid invest activ discontinu ops- net cash use invest flow financ activ payment conting net chang commerci paper short-term debt reduct long-term oblig net purchas non-controlling interests- proce interest rate swap terminations- proce long-term oblig net issuanc cost proce securit borrow payment premium debt extinguishment- proce issuanc common share tax benefit exercis stock purchas treasuri share net cash use /provid financ activ discontinu ops- net cash provid by/ use financ effect exchang rate chang cash equivalents- reclassfii asset held sale- net increas decreas chang fiscal year equival begin equival end fiscal year end june cowen
million except per-shar data
cowen compani
model assumptionstermin growth tax depreci chang work terminal- capit valuefre pv npv free npv futur excess valu total number valu per fiscal year end march cowen
million except per-shar data
compani report cowen compani
gross gross chang oper oper incom pre-tax pre-tax incom tax incom cont op attribut net incom attribut non-controlling net incom attribut net incom deal-rel net incom cont op includ non-recurring net incom non-recurring fulli dilut adj chang incom attribut year end march cowen
million except per-shar data
compani report cowen compani
gross gross chang oper oper incom pre-tax pre-tax incom tax incom cont op attribut net incom attribut non-controlling net incom attribut net incom deal-rel net incom cont op includ non-recurring net incom non-recurring fulli dilut adj chang incom attribut cowen
million
cowen compani
cash receiv inventori prepaid expens current properti plant equip intang asset equiti method invest chang non-current total liabil draft account short-term defer current portion long-term accru total current long-term long-term defer tax non-current redeem non-controlling stockhold equiti common addit paid-in retain accumul comprehens treasuri non-controlling total stockhold total liabil stockhold short-term liquid ratio current sale day purchas account inventori ratio inventori capit structur long-term solvenc ratio total debt total interest debt ratio return invest capit averag total asset averag stockhold equiti march cowen
million
compani report cowen compani
income/ loss flow oper activ depreci goodwil asset impair defer tax share-bas compens expense- charg credit associ last-in-first-out inventori loss gain sale busi equiti non-cash chang oper asset liabil receiv draft account defer revenue- net cash oper acquisit busi proce sale properti acquisit capit softwar issuanc common share dividend proceeds/ repay debt effect exchang rate chang cash cash net increase/ decreas cash equival begin cash equival end summari capit owner financ non-recur fiscal year end march cowen
million
compani report cowen compani
activitiesnet adjust reconcil net cash provid oper gain healthcar technolog net asset exchang net- goodwil asset impair loss equiti method invest chang healthcare- defer share-bas compens charg credit associ last-in-first-out inventori loss gain sale busi equiti investments- non-cash chang oper asset liabil net draft account defer claim litig settlement payment- net cash provid oper invest activitiespay properti plant capit softwar acquisit net cash cash equival proce sale busi asset payment receiv healthcar technolog net asset exchang net- restrict cash acquisitions- net cash use invest financ activitiesproce short-term repay short-term proce issuanc long-term repay long-term payment debt extinguishments- common stock share repurchas includ share surrend tax dividend net cash use financ effect exchang rate chang cash cash net decreas cash cash cash equival begin cash equival end supplement inform paid incom tax net fiscal year end march cowen
million except per share data
cowen compani
model assumptionstermin growth tax depreci chang net work terminal- valuefre pv npv free npv futur excess valu total number valu per year end decemb cowen
million except per share data
cowen compani
interseg net good interseg net cost good benefit interseg net benefit gross gross chang y/y- oper oper chang y/y- adj oper adj oper chang y/y- interest expens pre-tax pre-tax chang y/y- adj incom tax provis effect tax rate tax net adj net incom chang y/y- earn alloc particip net incom attribut non-controlling adj net incom attribut intang acquisition-rel financ goodwil impair long-liv loss divestitur net interest expens financ associ adj incom tax earn alloc particip net incom attribut non-controlling gaap net weight averag dilut share adj gaap chang y/i net oper net net incom attribut end decemb cowen
million except per share data
cowen compani
interseg net good interseg net cost good benefit interseg elimination- net benefit gross gross chang oper oper chang adj oper adj oper chang interest expens pre-tax pre-tax chang adj incom tax provis effect tax rate tax net adj net incom chang earn alloc particip net incom attribut non-controlling interest- adj net incom attribut intang acquisition-rel financ goodwil impairment- impair long-liv assets- store ration charge- loss divestitur net interest expens financ associ tax earn alloc particip net incom attribut non-controlling interest- net weight averag dilut share adj chang y/i net oper net net incom attribut cowen
million
cowen compani
cash short-term account receiv current current long-term properti equip intang asset separ account assets- total liabil account pharmaci claim discount care cost policyhold funds- accru insur short-term current portion long-term current long-term defer incom separ account liabilities- long-term insur long-term redeem non-controlling interest- stockhold equiti common treasuri share held trust- capit surplus- retain accumul comprehens total sharehold non-controlling total sharehold total liabil stockhold short-term liquid ratio current sale day purchas account day claim day ratio inventori capit structur long-term solvenc ratio total debt total interest ratio return invest capit averag total asset averag stockhold equiti decemb cowen
million
cowen compani
income/ loss adjust requir reconcil net incom net cash provid oper activ depreci goodwil loss settlement defin benefit pension plans- stock-bas loss earli extinguish debt- defer incom tax non-cash chang oper asset liabil net effect acquisit account receiv account payabl claim discount care cost payabl insur long-term net cash oper acquisit proce sale subsidiari properti acquisit issuanc common purchas treasuri stock- dividend proceeds/ purchas secur proceeds/ repay debt net increase/ decreas cash equival restrict cash begin cash equival restrict cash end cowen summari capit owner financ non-recur exclud non-recur itemsyear end decemb cowen
million
compani report cowen compani
activitiesnet adjust requir reconcil net incom net cash provid oper activ depreci goodwil impairments- loss settlement defin benefit pension plans- stock-bas loss earli extinguish defer incom tax non-cash chang oper asset liabil net effect acquisit account receiv account payabl pharmaci claim discount care cost payabl insur long-term net cash provid oper invest activitiesproce sale matur purchas purchas properti proce sale-lease-back acquisit net cash proce sale subsidiari assets- net cash use invest financ activitiesincreas decreas short-term proce issuanc long-term repay long-term purchas non-controlling interest payment conting deriv settlements- dividend proce exercis stock payment tax relat net share settlement equiti repurchas common net cash provid use financ effect exchang rate net decreas cash cash cash equival restrict cash begin cash equival restrict cash end year end decemb cowen
million except per-shar data
cowen compani
model assumptionstermin growth tax depreci chang work terminal- capit valuefre pv npv free npv futur excess valu total number valu per year end august cowen
million except per-shar data
compani report cowen compani
fifo cost fifo gross fifo gross chang lifo lifo gross lifo gross equiti earn ab- adjust equiti earn adjust oper adjust oper expens pre-tax pre-tax tax incom tax tax earn equiti method net earn non-controlling adjust net total net averag dilut adjust chang gross gross oper year end august cowen
million except per-shar data
compani report cowen compani
fifo cost fifo gross fifo gross chang lifo lifo gross lifo gross equiti earn ab- adjust equiti earn adjust oper adjust oper expens pre-tax pre-tax tax report incom tax incom tax tax earn equiti method net earn non-controlling adjust net total net averag dilut adjust chang gross gross oper cowen
million
compani report cowen compani
asset cash account receiv current current properti intang non-curr total current liabil short-term trade account accru expens incom current long-term defer incom non-curr stockhold equiti common paid-in employe stock loan retain accumul comprehens treasuri non-controlling total stockhold total liabil stockhold short-term liquid ratio current sale purchas acct ratio inventori structur long-term solvenc ratio total debt total interest ratio return invest capit averag total asset averag stockhold equiti year end august cowen
million
compani report cowen compani
income/ loss flow oper activ depreci gain previous held equiti interest- share base compens unreal gain fair valu adjustments- defer incom invest impair chang oper asset liabil receiv current non-curr account accru expens incom non-curr net cash oper acquisit properti acquisit issuanc common purchas treasuri dividend proceeds/ purchas secur proceeds/ repay debt net increase/ decreas cash equival begin cash equival end cowen summari oper capit owner financ non-recur exclud non-recur itemsfor year end august cowen
million
compani report cowen compani
flow oper activ net adjust reconcil net earn net cash depreci loss allianc boot call sale business- defer incom stock compens incom tax save employe stock plans- chang oper asset liabil account receiv current trade account accru expens incom non-curr asset net cash provid oper flow invest activitiesaddit properti proce sale leaseback transactions- purchas short-term invest held proce short-term invest held purchas short-term invest avail sale- proce sale short-term invest avail sale- return invest restrict cash- proce sale busi intang asset acquisit net cash payment proce sale invest invest allianc boots- net cash use invest flow financ activitiesnet payment short-term borrowings- payment long-term proce financ issuanc long-term debt- stock proce relat employe stock dividend net cash provid use financ effect exchang rate chang cash cash equivalents- chang equivalentsnet decreas cash cash cash equival begin cash equival end year end august cowen
million except per share data
cowen compani
model assumptionstermin growth tax depreci chang work terminal- capit valuefre pv npv free npv futur excess valu total number valu per year end decemb cowen
million except per share data
cowen compani
good gross gross chang sell gener administr adjust ebitda adjust adjust ebit chang fair valu redeem common shares- termin exist stock redempt agreement- equiti loss impair non-consolid entity- restructur impair non-recurring incom incom incom tax tax amort acquisition-rel intang conting consider impair non-consolid entity- incom tax impact net incom alloc prefer shareholders- gaap net incom common dilut weight average common share adjust gaap chang year-over-year net incom net end decemb cowen
million except per share data
cowen compani
good gross gross chang sell gener administr adjust ebitda adjust adjust ebit restructur impair charge- non-recurring incom incom incom tax tax net amort acquisition-rel intang conting consider impair non-consolid entity- incom tax impact net incom alloc prefer shareholders- gaap net incom common dilut weight average common share adjust gaap chang year-over-year net incom net cowen
million
cowen compani
asset account receiv defer incom prepaid expens current total current properti equip capit softwar intern use definite-liv intang asset invest non-consolid non-current total current liabil account borrow line short-term debt includ current portion long-term accru expens conting consideration- compens total current long-term debt less current conting consider less current portion- defer incom non-current liabilities- mandatorili redeem common shares- total stockhold equiti common addit paid-in retain accumul comprehens loss- total dplo sharehold non-controlling total sharehold total liabil stockhold short-term liquid ratio current sale purchas acct ratio inventori structur long-term solvenc ratio total debt total interest debt ratio return invest capit averag total asset averag stockhold equiti cowen
million
cowen compani
flow oper activ depreci goodwil impair definite-liv intang chang fair valu conting conting consider net provis doubt share-bas compens defer incom tax impair capit softwar intern use- loss gain sale dispos properti equipment- excess tax benefit relat share-bas awards- amort debt issuanc impair non-consolid chang oper asset liabil account account payabl asset net cash oper acquisit expenditur capit softwar intern expenditur issuanc common purchas treasuri stock- proceeds/ repay debt net increase/ decreas cash equival begin cash equival end cowen summari oper capit owner financ non-recur exclud non-recur itemsfor year end decemb cowen
million
compani report cowen compani
flow oper activ net adjust reconcil net incom net cash use oper activ depreci goodwil impairments- impair definite-liv intang assets- asset impairment- chang fair valu conting conting consider payment- net provis doubt share-bas compens equiti loss non-consolid defer incom tax impair capit softwar intern use- loss gain sale dispos properti excess tax benefit relat share-bas amort debt issuanc chang fair valu redeem common termin exist stock redempt certain expens paid notes- impair non-consolid entities- other- chang oper asset liabil account account payabl asset net cash use oper flow invest activ payment acquir busi net cash expenditur capit softwar intern expenditur properti capit invest loan non-consolid net cash use invest flow financ activ net payment line proce long-term debt- payment long-term proce public offer net transact proce sale prefer stock net transact payment made repurchas common payment made repurchas stock proce issuanc stock upon stock option exercises- excess tax benefit relat share-bas payment debt issuanc conting consider payments- sharehold distributions- net cash use provid financ net decreas increas cash equival begin equival end supplement disclosur cash flow inform paid paid incom year end decemb cowen
